Modelling the impact of immunization on the epidemiology of varicella zoster virus

被引:197
作者
Brisson, M
Edmunds, WJ
Gay, NJ
Law, B
De Serres, G
机构
[1] Publ Hlth Lab Serv, Ctr Communicable Dis Surveillance, London NW9 5EQ, England
[2] Univ Laval, Fac Med, CHUL Res Ctr, Publ Hlth Res Unit, Quebec City, PQ G1K 7P4, Canada
[3] Univ Manitoba, Dept Paediat & Child Hlth, Winnipeg, MB, Canada
关键词
D O I
10.1017/S0950268800004714
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
The objective of this study was to develop and apply a dynamic mathematical model of VZV transmission to predict the effect of different vaccination strategies on the age-specific incidence and outcome of infection. To do so a deterministic realistic age-structured model (RAS) was used which takes account of the increased potential for transmission within school aged groups. Various Vaccine efficacy scenarios, vaccine coverages and vaccination strategies were investigated and a sensitivity analysis of varicella incidence predictions to important parameters was performed. The model predicts that the overall (natural and breakthrough) incidence and morbidity of varicella would likely be reduced by mass vaccination of 12-month-old children. Furthermore, adding a catch-up campaign in the first year for 1-11 year olds seems to be the most effective strategy to reduce both. varicella incidence and morbidity tin the short and long term), though with the possible detrimental effect of increasing the incidence of zoster.
引用
收藏
页码:651 / 669
页数:19
相关论文
共 55 条
  • [31] HALL CB, 1995, PEDIATRICS, V95, P791
  • [32] THEORETICAL EPIDEMIOLOGIC AND MORBIDITY EFFECTS OF ROUTINE VARICELLA IMMUNIZATION OF PRESCHOOL-CHILDREN IN THE UNITED-STATES
    HALLORAN, ME
    COCHI, SL
    LIEU, TA
    WHARTON, M
    FEHRS, L
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1994, 140 (02) : 81 - 104
  • [33] Halloran ME, 1997, AM J EPIDEMIOL, V146, P789
  • [34] *HLTH ED AUTH, 1998, CHILDH IMM WAV, V15
  • [35] HOPESIMPSON RE, 1952, LANCET, V249, P499
  • [36] JOHNSON C, 1989, PEDIATRICS, V84, P418
  • [37] A long-term prospective study of varicella vaccine in healthy children
    Johnson, CE
    Stancin, T
    Fattlar, D
    Rome, LP
    Kumar, ML
    [J]. PEDIATRICS, 1997, 100 (05) : 761 - 766
  • [38] EFFICACY, IMMUNOGENICITY, SAFETY, AND USE OF LIVE ATTENUATED CHICKENPOX VACCINE
    KRAUSE, PR
    KLINMAN, DM
    [J]. JOURNAL OF PEDIATRICS, 1995, 127 (04) : 518 - 525
  • [39] OKA MERCK VARICELLA VACCINE IN HEALTHY-CHILDREN - FINAL REPORT OF A 2-YEAR EFFICACY STUDY AND 7-YEAR FOLLOW-UP-STUDIES
    KUTER, BJ
    WEIBEL, RE
    GUESS, HA
    MATTHEWS, H
    MORTON, DH
    NEFF, BJ
    PROVOST, PJ
    WATSON, BA
    STARR, SE
    PLOTKIN, SA
    [J]. VACCINE, 1991, 9 (09) : 643 - 647
  • [40] Law BJ, 1998, CAN NAT IMM C PARTN